INTRODUCTION
The X-linked, virtually complete deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT)1 activity results in a bizarre neurologic disorder, the Lesch-Nyhan syndrome (1) . After the initial description of the enzyme defect, several investigators noted low levels of HGPRT activity in hemolysate from patients with this syndrome (2, 3) while most found HGPRT activity undetectable (4) (5) (6) . More recently we have noted a wide range of HGPRT activity over time in the same patient suggesting that environmental factors might partly account for this discrepancy. Since the deficiency of HGPRT activity in the Lesch-Nyhan syndrome is associated with a normal level of catalytically-incompetent HGPRT protein (7, 8) represents one possible approach to the therapy of patients with this disease. The present report describes the influence of alterations in dietary purine content on HGPRT activity in erythrocytes from three patients with the Lesch-Nyhan syndrome. The changes observed in HGPRT activity are shown to be due to activation or inactivation of preformed HGPRT protein rather than a change in the absolute amount of the protein.
METHODS
Three patients with the classical Lesch-Nyhan syndrome were hospitalized on the Clinical Research Unit of Duke University Medical Center and received isocaloric diets which, as specified later, were either free of purines, contained a normal quantity of purines or contained the amount of adenine (10 mg/kg per day in four divided doses) present in the normal diet. Allopurinol (150-300 mg/day) was administered orally to each of the patients during the entire period of study.
HGPRT was assayed in hemolysate by a previously described radiochemical technique using guanine as substrate (8, 9) . [8 '4C]guanine (60 mCi/mmol) was obtained from New England Nuclear Corp., Boston, Mass. Identification of the product of the reaction as guanosine monophosphate (GMP) after incubation of mutant hemolysate with ["C]guanine, magnesium, and PP-ribose-P was confirmed in four different chromatographic systems as described previously (8) . Background (150-250 cpm) was defined by the radioactivity migrating with carrier GMP after incubation of a dialysed preparation of hemolysate with a reaction mixture which was complete except for the absence of PPribose-P. Each increment in specific activity of 0.001 nmol/ mg per h represented 75 counts above background. Orotate phosphoribosyltransferase (OPRT), and orotidylic decarboxylase (ODC) were assayed as described previously (10, 11) .
Density fractionation of intact circulating erythrocytes was also performed by a previously described technique (8) . human erythrocyte HGPRT was performed as previously described (8) . This technique was standardized by using known quantities of pure human HGPRT. Changes in concentration of 13 uag/ml (representing approximately 109 of the HGPRT protein present in 1 ml of hemolysate) could be detected (8) .
RESULTS
The effect of a purine-free diet on the level of HGPRT activity in hemolysate from three patients with the Lesch-Nyhan syndrome is illustrated in the left hand panel of Fig. 1 . Each patient demonstrated an increase in erythrocyte HGPRT activity beginning from 7 to 14 days after withdrawal of purines from the diet. In two of the three patients the activity was initially undetectable and rose at least three-to ninefold; in the third patient an increase to 54a/ above control values vas observed.
The right hand panel of Fig. 1 illustrates the reduction in HGPRT activity seen with the addition of adenine to a purine-free diet (patients D. C. and J. K.) or the resumption of a diet with a normal content of purines (patient V. P. (13) . In addition, this study suggests that dietary purine restriction could be of therapeutic benefit in some patients. Although we did not observe any striking alterations in the clinical course of our patients during purine restriction it is feasible that salutory effects may become evident after more prolonged dietary restriction.
